ATE341626T1 - Membranproteine aus säugetierzellen; verwandte reagentien - Google Patents

Membranproteine aus säugetierzellen; verwandte reagentien

Info

Publication number
ATE341626T1
ATE341626T1 AT98937993T AT98937993T ATE341626T1 AT E341626 T1 ATE341626 T1 AT E341626T1 AT 98937993 T AT98937993 T AT 98937993T AT 98937993 T AT98937993 T AT 98937993T AT E341626 T1 ATE341626 T1 AT E341626T1
Authority
AT
Austria
Prior art keywords
membrane proteins
mammal cells
related reagents
cells
proteins
Prior art date
Application number
AT98937993T
Other languages
English (en)
Inventor
Alexander B H Bakker
Joseph H Phillips Jr
Lewis L Lanier
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of ATE341626T1 publication Critical patent/ATE341626T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT98937993T 1997-08-01 1998-07-31 Membranproteine aus säugetierzellen; verwandte reagentien ATE341626T1 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US90490597A 1997-08-01 1997-08-01
US6371797P 1997-10-29 1997-10-29
US99082097A 1997-12-15 1997-12-15
US6969297P 1997-12-16 1997-12-16
US8916898P 1998-06-12 1998-06-12

Publications (1)

Publication Number Publication Date
ATE341626T1 true ATE341626T1 (de) 2006-10-15

Family

ID=27535631

Family Applications (2)

Application Number Title Priority Date Filing Date
AT98937993T ATE341626T1 (de) 1997-08-01 1998-07-31 Membranproteine aus säugetierzellen; verwandte reagentien
AT06019631T ATE523593T1 (de) 1997-08-01 1998-07-31 Membranproteine aus säugetierzellen und verwandte reagentien

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT06019631T ATE523593T1 (de) 1997-08-01 1998-07-31 Membranproteine aus säugetierzellen und verwandte reagentien

Country Status (8)

Country Link
EP (3) EP1003861B1 (de)
JP (3) JP2001512017A (de)
AT (2) ATE341626T1 (de)
AU (1) AU8661498A (de)
DE (1) DE69836082T2 (de)
ES (1) ES2274574T3 (de)
PT (1) PT1003861E (de)
WO (1) WO1999006557A2 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7196164B2 (en) 1997-07-08 2007-03-27 Human Genome Sciences, Inc. Secreted protein HHTLF25
EP1557425A3 (de) * 1997-07-08 2005-08-17 Human Genome Sciences, Inc. Humanes sekeretiertes Protein
AU2002220591A1 (en) * 2000-09-20 2002-04-02 Institut National De La Sante Et De La Recherche Medicale (I.N.S.E.R.M) Means for the identification of compounds capable of inhibiting karap-transduced signals
JP2004522742A (ja) 2000-12-08 2004-07-29 ベイラー　カレッジ　オブ　メディシン 免疫応答の改変において使用するためのｔｒｅｍ−１スプライス改変体
CA2433474A1 (en) * 2001-02-23 2002-09-06 Human Genome Sciences, Inc. 70 human secreted proteins
US20060099144A1 (en) 2004-11-08 2006-05-11 Schering Corporation Tumor association of MDL-1 and methods
AR059193A1 (es) * 2006-01-31 2008-03-12 Bayer Schering Pharma Ag Modulacion de la actividad de mdl-1 para el tratamiento de enfermedades inflamatorias
WO2008133857A1 (en) 2007-04-23 2008-11-06 Schering Corporation Anti-mdl-1 antibodies
EP2675467A4 (de) * 2011-02-18 2014-06-25 Merck Sharp & Dohme Verwendung von mdl-1-antagonisten zur behandlung von spondylarthropathie
WO2013043516A1 (en) 2011-09-23 2013-03-28 Merck Sharp & Dohme Corp. Mdl-1 ligand
RS67639B1 (sr) 2011-11-16 2026-02-27 Boehringer Ingelheim Int Anti il-36r antitela
AR090915A1 (es) 2012-05-04 2014-12-17 Intervet Int Bv Proteina de fusion de proteina linfopoyetina estromal timica canina con la region fc de igg
WO2014117121A1 (en) * 2013-01-28 2014-07-31 St. Jude Children's Research Hospital, Inc. A chimeric receptor with nkg2d specificity for use in cell therapy against cancer and infectious disease
CN105377287A (zh) * 2013-02-15 2016-03-02 托马斯杰弗逊大学 用于肿瘤成像的试剂盒
KR102211120B1 (ko) 2014-05-15 2021-02-03 내셔널 유니버시티 오브 싱가포르 변형된 천연 살해 세포 및 그의 용도
ES2891332T3 (es) 2014-09-17 2022-01-27 Novartis Ag Direccionamiento a células citotóxicas con receptores quiméricos para la inmunoterapia adoptiva
IL269553B2 (en) 2017-03-27 2025-10-01 Nat Univ Singapore Truncated NKG2D chimeric receptors and their uses in immunotherapy with natural killer cells
CN111801348A (zh) 2018-02-09 2020-10-20 新加坡国立大学 活化性嵌合受体及其在自然杀伤细胞免疫疗法中的用途
AU2019236105B2 (en) 2018-03-14 2025-07-31 Boehringer Ingelheim International Gmbh Use of anti-IL-36R antibodies for treatment of generalized pustular psoriasis
SG11202008976YA (en) 2018-04-02 2020-10-29 Nat Univ Singapore Neutralization of human cytokines with membrane-bound anti-cytokine non-signaling binders expressed in immune cells
CN108728527B (zh) * 2018-06-06 2020-06-09 青岛泱深生物医药有限公司 Hcst基因作为诊治子痫前期的靶标
EP3844186A4 (de) 2018-08-29 2022-08-17 National University of Singapore Verfahren zur spezifischen stimulation des überlebens und der expansion von genetisch modifizierten immunzellen
CA3120563A1 (en) 2018-11-26 2020-06-04 Nkarta, Inc. Methods for the simultaneous expansion of multiple immune cell types, related compositions and uses of same in cancer immunotherapy
WO2020180882A1 (en) 2019-03-05 2020-09-10 Nkarta, Inc. Cd19-directed chimeric antigen receptors and uses thereof in immunotherapy
EA202192405A1 (ru) 2019-03-08 2022-01-13 Бёрингер Ингельхайм Интернациональ Гмбх Составы антител против il-36r
EP4182022A1 (de) 2020-07-17 2023-05-24 Boehringer Ingelheim International GmbH Anti-il-36r-antikörper zur behandlung neutrophiler dermatosen
EP4305207A2 (de) 2021-03-12 2024-01-17 Boehringer Ingelheim International GmbH Biomarker im zusammenhang mit der behandlung von anti-il-36r-antikörpern in generalisierter pustularer psoriasis

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3645090A (en) 1969-06-19 1972-02-29 Citizen Watch Co Ltd Day-date quick-adjuster for calender timepiece
US3940475A (en) 1970-06-11 1976-02-24 Biological Developments, Inc. Radioimmune method of assaying quantitatively for a hapten
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US3817837A (en) 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US3939350A (en) 1974-04-29 1976-02-17 Board Of Trustees Of The Leland Stanford Junior University Fluorescent immunoassay employing total reflection for activation
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4277437A (en) 1978-04-05 1981-07-07 Syva Company Kit for carrying out chemically induced fluorescence immunoassay
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
US4659678A (en) 1982-09-29 1987-04-21 Serono Diagnostics Limited Immunoassay of antigens
NZ207394A (en) 1983-03-08 1987-03-06 Commw Serum Lab Commission Detecting or determining sequence of amino acids
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4859609A (en) 1986-04-30 1989-08-22 Genentech, Inc. Novel receptors for efficient determination of ligands and their antagonists or agonists
CA2247207A1 (en) * 1995-02-28 1996-09-06 National Jewish Center For Immunology And Respiratory Medicine Peptidyl compounds comprising an itim motif which regulate hematopoietic function and their use
WO1997020046A1 (en) * 1995-11-30 1997-06-05 Schering Corporation Dnam, an nk antigen and adhesion molecule of the immunoglobulin superfamily
EP0972029A1 (de) * 1997-03-07 2000-01-19 Human Genome Sciences, Inc. 70 humane sekretierte proteine
WO1998049292A2 (fr) * 1997-04-30 1998-11-05 Institut National De La Sante Et De La Recherche Medicale (Inserm) Polypeptides associes a des recepteurs activateurs et leurs applications biologiques
CA2295474A1 (en) * 1997-07-08 1999-01-21 Human Genome Sciences, Inc. 123 human secreted proteins
CA2297109A1 (en) * 1997-08-01 1999-02-11 Genset 5' ests for secreted proteins expressed in muscle and other mesodermal tissues
DE69835751T2 (de) * 1997-08-01 2007-10-04 Serono Genetics Institute S.A. 5' ests für proteine, die nicht gewebespezifisch sind

Also Published As

Publication number Publication date
DE69836082D1 (de) 2006-11-16
EP1003861A2 (de) 2000-05-31
JP2010099077A (ja) 2010-05-06
EP1798287A3 (de) 2007-11-14
EP1798286A3 (de) 2007-11-14
AU8661498A (en) 1999-02-22
EP1798286B1 (de) 2011-09-07
DE69836082T2 (de) 2007-05-10
JP4855513B2 (ja) 2012-01-18
EP1798287A2 (de) 2007-06-20
PT1003861E (pt) 2007-01-31
WO1999006557A2 (en) 1999-02-11
ES2274574T3 (es) 2007-05-16
JP2001512017A (ja) 2001-08-21
EP1003861B1 (de) 2006-10-04
JP2010099076A (ja) 2010-05-06
WO1999006557A3 (en) 1999-05-20
ATE523593T1 (de) 2011-09-15
EP1798286A2 (de) 2007-06-20

Similar Documents

Publication Publication Date Title
ATE523593T1 (de) Membranproteine aus säugetierzellen und verwandte reagentien
ATE397660T1 (de) Zelloberflächen-antigen aus säugetieren und verwandte reagenzien
LU91756I2 (fr) Denosumab
WO1998027114A3 (en) Mammalian cell surface antigens; related reagents
MY157028A (en) Mammalian cytokine, related reagents
UA42760C2 (uk) Спосіб спрямування клітинної імунної відповіді проти віл-інфікованої клітини ссавця,білковий мембранозв'язаний химерний рецептор,днк,яка кодує химерний рецептор,вектор,що її містить
NL300137I1 (nl) Recombinante proteïnen van virussen geassocieerd met het
ATE353965T1 (de) An g-protein gekoppelte rezeptoren und deren verwendungen
DK0526452T3 (da) Hybridimmunoglobuliner
ATE313633T1 (de) Expressionsvektoren die für bispezifische proteine kodieren, und verfahren zur herstellung von biologisch-aktiven bispezifischen fusionsproteine in zellen von säugertieren
AR014891A1 (es) Genes aislados de proteinas de membranas de mamiferos; reactivos relacionados
ATE456656T1 (de) Isolierte gene aus säuger monozyten und betreffende reagentien
DK1616878T3 (da) Udskilte og membranspændende polypeptider samt nukleinsyrer kodende for disse
WO1999047673A3 (en) Isolated mammalian membrane protein genes and related reagents
DE60023691D1 (de) T-bet zusammensetzungen und deren vervendungsmethoden
MX9603266A (es) Genes de timocina de mamiferos.
EP0997476A3 (de) Antikörper gegen ein Antigen auf Langerhans Zellen in Säugetieren und deren Verwendungen
WO1998031810A3 (en) Mammalian chemokines; receptors; reagents; uses
EP1867720A3 (de) Für Zelloberflächenantigene von Säugetieren kodierende gereinigte Gene; Proteine und Antikörper
ECSP982583A (es) Genes aislados de proteinas de membranas de mamiferos reactivos relacionados
WO2000034335A3 (en) 'death domain' containing receptors
WO2004033648A3 (en) Isolated mammalian membrane protein genes; related reagents
WO2000032746A3 (en) Netrin-like and ependymin-like nucleic acids and polypeptides and uses thereof

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1003861

Country of ref document: EP